United States · FDA National Drug Code directory
Pentasa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54092-189_42661699-8fcc-40da-a05d-91906f9973e8
- Product NDC
- 54092-189
- Form
- CAPSULE
- Composition / generic term
- mesalamine
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 19930510
- Source listing expiry
- 20261231
Source-listed ingredients
- MESALAMINE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 240 CAPSULE in 1 BOTTLE (54092-189-81) · 54092-189-81
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →